Frankfurt - Delayed Quote EUR
Pure Biologics S.A. (PQB.F)
2.0260
-0.0400
(-1.94%)
At close: April 28 at 8:13:26 AM GMT+2
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
95
95
662
254
572
Cost of Revenue
2,668
2,669
6,069
4,281
4,508
Gross Profit
-2,573
-2,574
-5,407
-4,027
-3,936
Operating Expense
36,300
27,236
19,274
6,460
7,620
Operating Income
-38,873
-29,810
-24,681
-10,487
-11,556
Net Non Operating Interest Income Expense
-3,491
-3,552
-130
-134
-320
Pretax Income
-44,696
-35,694
-25,603
-11,765
-11,756
Net Income Common Stockholders
-19,917
-35,694
-25,603
-11,765
-11,756
Diluted NI Available to Com Stockholders
-19,917
-35,694
-25,603
-11,765
-11,756
Basic EPS
-6.02
-11.19
-11.36
-5.30
-7.11
Diluted EPS
-6.02
-11.19
-11.36
-5.30
-7.11
Basic Average Shares
3,360.5170
3,189.4740
2,254
2,221.1230
1,654
Diluted Average Shares
3,503.7490
3,288.3230
2,254
2,254
1,681.8690
Total Operating Income as Reported
-40,781
-31,718
-24,629
-10,482
-11,554
Rent Expense Supplemental
347
237
1,914
1,978
2,417
Total Expenses
38,968
29,905
25,343
10,741
12,128
Net Income from Continuing & Discontinued Operation
-19,917
-35,694
-25,603
-11,765
-11,756
Normalized Income
-42,771
-33,769
-24,834
-10,686
-11,756
Interest Income
486
281
199
93
29
Interest Expense
3,977
3,833
329
227
349
Net Interest Income
-3,491
-3,552
-130
-134
-320
EBIT
-40,719
-31,861
-25,274
-11,538
-11,407
EBITDA
-34,835
-26,077
-22,777
-8,618
-8,297
Reconciled Cost of Revenue
2,668
2,669
6,069
4,281
4,508
Reconciled Depreciation
5,884
5,784
2,497
2,920
3,110
Net Income from Continuing Operation Net Minority Interest
-44,696
-35,694
-25,603
-11,765
-11,756
Total Unusual Items Excluding Goodwill
-1,925
-1,925
-769
-1,079
--
Total Unusual Items
-1,925
-1,925
-769
-1,079
--
Normalized EBITDA
-32,910
-24,152
-22,008
-7,539
-8,297
12/31/2020 - 1/27/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
6YG.MU Immunocore Holdings plc
26.80
0.00%
PHR.WA Pharmena S.A.
4.3100
+0.23%
9Y4.SG Ryvu Therapeutics SA
7.59
+8.74%
6YG.BE Immunocore Holdings PLC
27.00
+2.27%
0VQ0.F PureTech Health plc
13.60
-6.21%
OXOA.BE Oxford BioMedica PLC
3.5800
+1.70%
URT.WA Urteste S.A.
80.00
+2.04%
XI3.F Bioceltix S.A.
22.80
-0.22%
1B1.MU Molecure SA
1.9700
0.00%
BCX.WA Bioceltix S.A.
116.00
+0.69%